Tel Aviv University-led research has found that infants prescribed acid-suppressive medications during their first six months ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Widespread use of digital technology seems to be associated with lower rates of cognitive decline in adults older than 50 ...

Researchers have found in a new study that in patients with heart failure and iron deficiency, ferric carboxymaltose did not ...

Authors say limiting certain food additives may be an effective public health strategy to prevent diabetes. (HealthDay News) — Two widely consumed food additive mixtures may increase type 2 diabetes ...

The antiviral drug tecovirimat (Tpoxx) didn't accelerate lesion clearance in adults and children with clade 1 mpox ...

Adding Farxiga (dapagliflozin) to standard care significantly reduced the risk of death or worsening heart failure in older ...

The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for unresectable or metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

The U.S. Food and Drug Administration has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for ...

Corporation announced new data presented at the American College of Cardiology, ACC, 74th Annual Scientific Session and Expo held ...